Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 2: (3-Substituted-5-halo-2-pyridinyl)guanidines
摘要:
Based on previous modeling predictions, a series of (3-substituted-5-chloro-2-pyridinyl)guanidines have been designed with good potency and selectivity for urokinase-type plasminogen activator (uPA). Compound 3 has a K-i of 0.17 muM and greater than 300-fold selectivity with respect to tPA and plasmin (C) 2002 Elsevier Science Ltd. All rights reserved.
Pyridinium N-2′-pyridylaminide: radical cyclization for the synthesis of benzonaphthyridine derivatives
摘要:
The synthesis of benzonaphthyridine derivatives that incorporate a 2-aminopyridine moiety can be performed by intramolecular radical pyridylation of the appropriate substrates, obtained from pyridinium N-2'-pyridylaminide, using TTMSS and AIBN. similar to 2007 Elsevier Ltd. All rights reserved.
Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 2: (3-Substituted-5-halo-2-pyridinyl)guanidines
作者:Christopher G Barber、Roger P Dickinson
DOI:10.1016/s0960-894x(01)00702-8
日期:2002.1
Based on previous modeling predictions, a series of (3-substituted-5-chloro-2-pyridinyl)guanidines have been designed with good potency and selectivity for urokinase-type plasminogen activator (uPA). Compound 3 has a K-i of 0.17 muM and greater than 300-fold selectivity with respect to tPA and plasmin (C) 2002 Elsevier Science Ltd. All rights reserved.
Pyridinium N-2′-pyridylaminide: radical cyclization for the synthesis of benzonaphthyridine derivatives
The synthesis of benzonaphthyridine derivatives that incorporate a 2-aminopyridine moiety can be performed by intramolecular radical pyridylation of the appropriate substrates, obtained from pyridinium N-2'-pyridylaminide, using TTMSS and AIBN. similar to 2007 Elsevier Ltd. All rights reserved.